SLC5A2 and hydrops fetalis: However, SGLT2 inhibitors reduced a number of serious HF events and improved clinical status in HF patients regardless of volume overload and consequently independently from the baseline level [42,43,44], pool of electrolytes and metabolic profile [45,46].